Researchers
Protecting my results
Developing my project
Involving companies
Thinking about Entrepreneurship
Pathway for Pre-Entrepreneurship of Inserm Transfert
The Pathway for Pre-Entrepreneurship Meetings
Human Health Startup Factory
Companies
An exceptional offer
A response dedicated to your requirements
Our strategic innovation domains
Investors
Inserm Transfert
Our mission and successes
Governance
Our history
Our quality policy
Careers
Technology offers
Notre vision
Postes à pourvoir
Nos expertises métiers
Paroles de collaborateurs
Contacts
Notre vision
Postes à pourvoir
Nos expertises métiers
Paroles de collaborateurs
Actualités
Notre vision
Postes à pourvoir
Nos expertises métiers
Paroles de collaborateurs
FR
FR
EN
My Account
Home
Visit our website
Contact us
News
Back to results
Factor h fragment for use as an anti-angiogenic agent
The invention relates to a complement factor H fragment for use in the therapy and/or prophylaxis of a disease involving neovascularization. POC in vivo in a choroidal neovascularization model
Keywords:
Dry AMD - neovascularization
Patent Application number:
PRIO : 15 63465
PCT/FR2016/053689
Inventors:
Toufik ABACHE
Frédéric MASCARELLI
Virginie DINET
Sylvie JORIEUX
Reference:
BIO14280-T1
Application:
Therapeutic
Therapy Area:
Macular Degeneration
Type of patent:
Method
Field of development:
Drug
Stage of development:
Hit - validation in vivo
Type of Product:
Synthetic peptide
Business Developper
contact
Anne COCHI
Business Development Manager
Phone
E-mail
Patent filling date:
30-12-2015
You might also be interested in
View more
Informations